Analysis of tyrosine kinase NPM-ALK (p80) in anaplastic large cell lymphoma: Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis.

被引：0
|
作者：
Ergin, M [1 ]
Denning, MF [1 ]
Izban, KF [1 ]
Amin, HM [1 ]
Pooley, RJ [1 ]
Martinez, RL [1 ]
Alkan, S [1 ]
机构：
[1] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1473
引用
收藏
页码：341A / 341A
页数：1
相关论文
共 50 条
  • [1] Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein
    Ergin, M
    Denning, MF
    Izban, KF
    Amin, HM
    Martinez, RL
    Saeed, S
    Alkan, S
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (09) : 1082 - 1090
  • [2] ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors
    Lovisa, Federica
    Cozza, Giorgio
    Cristiani, Andrea
    Cuzzolin, Alberto
    Albiero, Alessandro
    Mussolin, Lara
    Pillon, Marta
    Moro, Stefano
    Basso, Giuseppe
    Rosolen, Angelo
    Bonvini, Paolo
    PLOS ONE, 2015, 10 (04):
  • [3] Involvement of oncogenic tyrosine kinase NPM-ALK in trifluoperazine-induced cell cycle arrest and apoptosis in ALK+ anaplastic large cell lymphoma
    Hu, Linlin
    Zhang, Xiaonan
    Wang, Jian
    Wang, Song
    Amin, Hesham M.
    Shi, Ping
    HEMATOLOGY, 2018, 23 (05) : 284 - 290
  • [4] STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma
    Wu, Chengsheng
    Molavi, Ommoleila
    Zhang, Haifeng
    Gupta, Nidhi
    Alshareef, Abdulraheem
    Bone, Kathleen M.
    Gopal, Keshav
    Wu, Fang
    Lewis, Jamie T.
    Douglas, Donna N.
    Kneteman, Norman M.
    Lai, Raymond
    BLOOD, 2015, 126 (03) : 336 - 345
  • [5] Ribozyme-mediated cleavage of the NPM-ALK transcript coding for chimeric tyrosine kinase associated with anaplastic large cell lymphoma.
    Hübinger, G
    Wehnis, E
    Maurer, U
    Morris, SW
    Bergmann, L
    BLOOD, 1999, 94 (10) : 598A - 598A
  • [6] The effect of the cyclin-dependent kinase inhibitor flavopiridol on anaplastic large cell lymphoma cells and relationship with NPM-ALK kinase expression and activity
    Bonvini, Paolo
    Zorzi, Elisa
    Mussolin, Lara
    Monaco, Giovanni
    Pigazzi, Martina
    Basso, Giuseppe
    Rosolen, Angelo
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (07): : 944 - 955
  • [7] Trka, a Novel Binding Partner of NPM-ALK Oncogenic Tyrosine Kinase, Facilitates the Survival of T-Cell Anaplastic Large-Cell Lymphoma
    Shi, Wenyu
    George, Suraj Konnath
    Curry, Choladda V.
    Alkan, Serhan
    Amin, Hesham M.
    BLOOD, 2014, 124 (21)
  • [8] RESISTANCE TO ANAPLASTIC LYMPHOMA KINASE (ALK) TYROSINE KINASE INHIBITORS (TKIs) IN PAEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
    Hare, L.
    Prokoph, N.
    Burke, A.
    Turner, S.
    LEUKEMIA RESEARCH, 2022, 121 : S14 - S16
  • [9] Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8+ T cell responses in children with NPM-ALK+ anaplastic large cell lymphoma
    Singh, V. K.
    Werner, S.
    Hackstein, H.
    Lennerz, V.
    Reiter, A.
    Woelfel, T.
    Damm-Welk, C.
    Woessmann, W.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 186 (01): : 96 - 105
  • [10] IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells
    Shi, Ping
    Lai, Raymond
    Lin, Quan
    Iqbal, Abid S.
    Young, Leah C.
    Kwak, Larry W.
    Ford, Richard J.
    Amin, Hesham M.
    BLOOD, 2009, 114 (02) : 360 - 370
12345